GenMont Biotech

GenMont Biotech EBIT Margin

The EBIT Margin (Operating Margin) of GenMont Biotech (3164.TW) as of Oct 21, 2026 is 14.39 %. In the previous year, EBIT Margin (Operating Margin) was 10.41 % — a change of 38.26% (higher).

EBIT Margin

14.39 %

YoY

38.26%

Last updated:

EBIT Margin (Operating Margin) of GenMont Biotech is 2025 14.39 % . EBIT Margin (Operating Margin) of GenMont Biotech was 2024 10.41 % . It decreases by 38.26% higher compared to the previous year.

For GenMont Biotech, the operating (EBIT) margin of 14.4% is down versus 33.5% a few years ago.

The GenMont Biotech EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
30.21 TWD
Jan 1, 2019
22.17 TWD
Jan 1, 2020
23.68 TWD
Jan 1, 2021
33.53 TWD
Jan 1, 2022
16.33 TWD
Jan 1, 2023
2.20 TWD
Jan 1, 2024
10.41 TWD
Jan 1, 2025
14.39 TWD
The GenMont Biotech EBIT Margin history
YEAREBIT MarginYoY
14.39 %+38.26%
10.41 %+373.75%
2.20 %-86.54%
16.33 %-51.30%
33.53 %+41.61%
23.68 %+6.79%
22.17 %-26.61%
30.21 %+5.45%
28.65 %-955.63%
-3.35 %-61.05%
-8.60 %-66.38%
-25.57 %-13,983.88%
0.18 %-241.64%
-0.13 %+123.81%
-0.06 %-119.08%
0.30 %+11.61%
0.27 %+8.30%
0.25 %-5.18%
0.27 %+30.07%
0.20 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GenMont Biotech Stock analysis

What does GenMont Biotech do? GenMont Biotech Inc. is a biotechnology company based in Tainan, Taiwan, specializing in the research, development, manufacturing, and sale of probiotic supplements. Its products, including various strains of lactobacillus, target immune support against dust allergies and digestive health. The company operates domestically in Taiwan and internationally, having listed on the stock market in 2003. GenMont Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GenMont Biotech stock

EBIT Margin (Operating Margin) of GenMont Biotech is 14.39 % in 2025.

EBIT Margin (Operating Margin) of GenMont Biotech changed from 10.41 % to 14.39 %, representing a 38.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) GenMont Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s GenMont Biotech with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — GenMont Biotech

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — GenMont Biotech